Paediatric virology and human papillomaviruses: An update.
Paediatric virology and human papillomaviruses: An update.
Exp Ther Med. 2019 Jun;17(6):4337-4343
Authors: Mammas IN, Dalianis T, Doukas SG, Zaravinos A, Achtsidis V, Thiagarajan P, Theodoridou M, Spandidos DA
Abstract
Almost 10 years ago, in October, 2008, the scientist who reported for the first time the association between human papillomaviruses (HPV) and cervical cancer, was awarded with the Nobel prize. In the years that followed, Professor Harald zur Hausen actively supported the value of the HPV vaccination in the prevention of different types of cancer and highlighted the necessity of its introduction in both girls and boys. However, to date, in the majority of countries, HPV vaccination among male adolescents has not been implemented into the national vaccination schemes, while in several countries, including Greece, the participation rate to HPV vaccination among female adolescents still remains low. Recent data indicate that catch-up HPV vaccination among young women has been extremely useful and has exhibited a significant effect in decreasing the prevalence of HPV. While the marketed current HPV vaccines prevent anogenital HPV infection, their impact on the natural history of oral HPV and their efficacy in preventing HPV-related head and neck carcinomas need to be further investigated. Juvenile onset recurrent respiratory papillomatosis, as well as HPV-associated conjunctival papillomas continue to be observed in childho...
Source: Experimental and Therapeutic Medicine - Category: General Medicine Tags: Exp Ther Med Source Type: research
More News: Boys | Cancer | Cancer & Oncology | Cancer in Adolescents | Cancer Vaccines | Carcinoma | Cervical Cancer | Childhood Cancer | General Medicine | Genital Warts | Girls | Greece Health | Head and Neck Cancer | Oral Cancer | Papillomatosis | Pediatrics | Respiratory Medicine | Vaccines | Virology | Women | Workshops